FDA Letter to Sunovion Misleading Marketing
Misleading Marketing of Respiratory Drug Brovana. In a letter released on Tuesday, the U.S. Food and Drug Administration (FDA) charges that Sunovion Pharmaceuticals Inc. deceptively promoted its respiratory drug Brovana [...]